These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24189293)

  • 1. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells.
    Takahashi M; Matsuoka Y; Sumide K; Nakatsuka R; Fujioka T; Kohno H; Sasaki Y; Matsui K; Asano H; Kaneko K; Sonoda Y
    Leukemia; 2014 Jun; 28(6):1308-15. PubMed ID: 24189293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Updated human hematopoietic stem cell findings: purification of human hematopoietic stem cells and elucidation of their hierarchy].
    Sonoda Y
    Rinsho Ketsueki; 2018; 59(10):1861-1871. PubMed ID: 30305486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells.
    Matsuoka Y; Takahashi M; Sumide K; Kawamura H; Nakatsuka R; Fujioka T; Sonoda Y
    Cell Transplant; 2017 Jun; 26(6):1043-1058. PubMed ID: 27938494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo dynamics of human cord blood-derived CD34(-) SCID-repopulating cells using intra-bone marrow injection.
    Kimura T; Matsuoka Y; Murakami M; Kimura T; Takahashi M; Nakamoto T; Yasuda K; Matsui K; Kobayashi K; Imai S; Asano H; Nakatsuka R; Uemura Y; Sasaki Y; Sonoda Y
    Leukemia; 2010 Jan; 24(1):162-8. PubMed ID: 19798093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a high-resolution purification method for precise functional characterization of primitive human cord blood-derived CD34-negative SCID-repopulating cells.
    Ishii M; Matsuoka Y; Sasaki Y; Nakatsuka R; Takahashi M; Nakamoto T; Yasuda K; Matsui K; Asano H; Uemura Y; Tsuji T; Fukuhara S; Sonoda Y
    Exp Hematol; 2011 Feb; 39(2):203-213.e1. PubMed ID: 21112372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7.
    Gallacher L; Murdoch B; Wu DM; Karanu FN; Keeney M; Bhatia M
    Blood; 2000 May; 95(9):2813-20. PubMed ID: 10779426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD34-negative hematopoietic stem cells: The current understanding of their biological nature.
    Sonoda Y
    Exp Hematol; 2021 Apr; 96():13-26. PubMed ID: 33610645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
    Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
    J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.
    Mazurier F; Doedens M; Gan OI; Dick JE
    Nat Med; 2003 Jul; 9(7):959-63. PubMed ID: 12796774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells.
    Matsuoka Y; Nakatsuka R; Sumide K; Kawamura H; Takahashi M; Fujioka T; Uemura Y; Asano H; Sasaki Y; Inoue M; Ogawa H; Takahashi T; Hino M; Sonoda Y
    Stem Cells; 2015 May; 33(5):1554-65. PubMed ID: 25537923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein.
    Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S
    Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.
    Wang J; Kimura T; Asada R; Harada S; Yokota S; Kawamoto Y; Fujimura Y; Tsuji T; Ikehara S; Sonoda Y
    Blood; 2003 Apr; 101(8):2924-31. PubMed ID: 12480697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells.
    Sumide K; Matsuoka Y; Kawamura H; Nakatsuka R; Fujioka T; Asano H; Takihara Y; Sonoda Y
    Nat Commun; 2018 Jun; 9(1):2202. PubMed ID: 29875383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells.
    Hess DA; Wirthlin L; Craft TP; Herrbrich PE; Hohm SA; Lahey R; Eades WC; Creer MH; Nolta JA
    Blood; 2006 Mar; 107(5):2162-9. PubMed ID: 16269619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
    Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
    Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection.
    Kimura T; Asada R; Wang J; Kimura T; Morioka M; Matsui K; Kobayashi K; Henmi K; Imai S; Kita M; Tsuji T; Sasaki Y; Ikehara S; Sonoda Y
    Stem Cells; 2007 Jun; 25(6):1348-55. PubMed ID: 17303816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AC133+CD38-, but not the rhodamine-low, phenotype tracks LTC-IC and SRC function in human cord blood ex vivo expansion cultures.
    Ito CY; Kirouac DC; Madlambayan GJ; Yu M; Rogers I; Zandstra PW
    Blood; 2010 Jan; 115(2):257-60. PubMed ID: 19897585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells secreting angiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potential.
    Khoury M; Drake A; Chen Q; Dong D; Leskov I; Fragoso MF; Li Y; Iliopoulou BP; Hwang W; Lodish HF; Chen J
    Stem Cells Dev; 2011 Aug; 20(8):1371-81. PubMed ID: 21142526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.
    Bhatia M; Wang JC; Kapp U; Bonnet D; Dick JE
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5320-5. PubMed ID: 9144235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.